COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS
申请人:Matsuzaki Yuichi
公开号:US20110009454A1
公开(公告)日:2011-01-13
Disclosed is a composition for agricultural use, which is used for controlling or preventing plant diseases caused by plant pathogens. The composition for agricultural use contains a compound represented by formula (1), a salt thereof or a hydrate of the compound or the salt. (1) [In the formula, Z represents an oxygen atom, a sulfur atom or NR
Z
; and E represents a furyl group, a thienyl group, a pyrrolyl group, a tetrazolyl group, a thiazolyl group, a pyrazolyl group, a phenyl group or the like.]
COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY
申请人:Chen, Kuenfeng
公开号:EP3345894A1
公开(公告)日:2018-07-11
A compound having a chemical structure of formula I, wherein n is 0 or 1, X is N or C-R1, R1 is H or Cl, R2 and R3 are independently H, a halogen or an alkyl group, Ar is a substituted or unsubstituted phenylene or naphthylene group, with the substituted or unsubstituted phenylene group being A or B, and the naphthylene group being C, R4 is H, a halogen or an alkyl group, R5 is H, a halogen, an alkyl group, an alkoxyl group or a hydroxyl group, R6 is H or a hydroxyl group, and R7 is a substituted or unsubstituted aryl group. The compound has SHP-1 agonist activity, and can be used to treat cancer.
一种具有式 I 化学结构的化合物,其中 n 为 0 或 1,X 为 N 或 C-R1,R1 为 H 或 Cl,R2 和 R3 独立地为 H、卤素或烷基,Ar 为取代或未取代的亚苯基或亚萘基、R4 是 H、卤素或烷基,R5 是 H、卤素、烷基、烷氧基或羟基,R6 是 H 或羟基,R7 是取代或未取代的芳基。该化合物具有 SHP-1 激动剂活性,可用于治疗癌症。
[EN] COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY<br/>[FR] COMPOSÉ PRÉSENTANT UNE ACTIVITÉ AGONISTE DE LA PROTÉINE TYROSINE PHOSPHATASE SHP-1<br/>[ZH] 具有蛋白酪氨酸磷酸酶SHP-1激动剂活性的化合物
ARYL AMINE SUBSTITUTED PYRIMIDINE AND QUINAZOLINE AND THEIR USE AS ANTICANCER DRUGS
申请人:National Yang-Ming University
公开号:US20150246891A1
公开(公告)日:2015-09-03
A series of mono- and di-substituted quinazoline and pyrimidine derivatives based on the skeleton of erlotinib (an EGFR inhibitor) were synthesized and their bioactivities against hepatocellular carcinoma and human lung adenocarcinoma were evaluated.